Leede Jones Gab Stock Recommendations and Price Targets

This is a list of recent ratings by Leede Jones Gab.

Date	Company Name	Action	Current Price	Rating	Impact on Share Price
5/9/2024	TAU Thesis Gold	Upgrade	C$1.00	Strong-Buy	N/A
5/9/2024	DR Medical Facilities	Upgrade	C$16.00	Hold ➝ Buy	N/A
2/13/2024	BRC Blackrock Silver	Reiterated Rating	C$0.00	Speculative Buy	N/A
1/31/2024	PHA Premier Health of America	Reiterated Rating	C$0.00	Buy	N/A
11/13/2023	EXE Extendicare	Upgrade	C$10.00	Hold ➝ Buy	N/A
9/19/2023	CRDL Cardiol Therapeutics	Reiterated Rating	$1.00	Speculative Buy	Low
8/16/2023	ACD Accord Financial	Reiterated Rating	C$4.00	Buy	N/A
7/17/2023	PMN ProMIS Neurosciences	Reiterated Rating	$1.00	Speculative Buy	Low
4/20/2023	SGD Snowline Gold	Reiterated Rating	C$5.00	Buy	N/A
3/17/2023	CPH Cipher Pharmaceuticals	Reiterated Rating	C$15.00	Buy	N/A
1/5/2023	THTX Theratechnologies	Upgrade	$2.00	Hold ➝ Speculative Buy	Low
1/5/2023	TH Theratechnologies	Upgrade	C$3.00	Hold ➝ Speculative Buy	N/A
11/11/2022	DR Medical Facilities	Downgrade	C$16.00	Buy ➝ Hold	N/A
3/4/2022	ONCY Oncolytics Biotech	Reiterated Rating	$1.00	Speculative Buy	Low
3/4/2022	ONC Oncolytics Biotech	Reiterated Rating	C$1.00	Speculative Buy	N/A